Bronchospasm symptoms and conditions

READ THIS BEFORE YOU GET VACCINATED:

This is from Merck's website:

Serious Adverse Reactions in the Entire Study Population
A total of 237 subjects out of 25,274 total subjects (9- through 45-year-old girls and women; and 9-through 15-year-old boys) who received both GARDASIL (N = 13,686) and AAHS control (N = 11,004) or saline placebo (N = 584) reported a serious systemic adverse reaction following any vaccination visit during the clinical trials for GARDASIL.

Out of the entire study population (25,274 subjects), only 0.05% of the reported serious systemic adverse reactions were judged to be vaccine related by the study investigator. The most frequently reported serious systemic adverse reactions for GARDASIL compared to AAHS control or saline placebo and regardless of causality were:

Headache ,
Gastroenteritis ,
Appendicitis ,
Pelvic inflammatory disease ,
Urinary tract infection ,
Pneumonia ,
Pyelonephritis ,
Pulmonary embolism .
One case (0.007% GARDASIL: 0.0% AAHS Control or Saline Placebo) of bronchospasm; and
2 cases (0.02% GARDASIL: 0.0% AAHS Control or Saline Placebo) of asthma were reported as serious systemic adverse reactions that occurred following any vaccination visit.
In addition, there was 1 subject in the clinical trials, in the group that received GARDASIL, who reported two injection-site serious adverse reactions (injection-site pain and injection-site joint movement
impairment).

Systemic Autoimmune Disorders in Girls and Women 9 Through 26 Years of Age

In the clinical studies, 9- through 26-year-old girls and women were evaluated for new medical conditions that occurred over the course of follow-up. New medical conditions potentially indicative of a systemic autoimmune disorder seen in the group that received GARDASIL...includes all subjects who received at least one dose of GARDASIL.

Of the 10,706 who received Gardasil:

120 developed Arthralgia/Arthritis/Arthropathy
4 developed Autoimmune Thyroiditis
10 Coeliac Disease
2 Diabetes Mellitus Insulin-dependent
2 Erythema Nodosum
27 Hyperthyroidism***
35 Hypothyroidism†
7 Inflammatory Bowel Disease‡
2 Multiple Sclerosis
2 Nephritis¶
2 Optic Neuritis
4 Pigmentation Disorder§
13 Psoriasis#
3 Raynaud's Phenomenon
6 Rheumatoid Arthritis††
2 Scleroderma/Morphea
1 Stevens-Johnson Syndrome
1 Systemic Lupus Erythematosus
3 Uveitis

6.2 Post-Marketing Experience
The following adverse events have been spontaneously reported during post-approval use of GARDASIL. Because these events were reported voluntarily from a population of uncertain size, it is not possible to reliably estimate their frequency or to establish a causal relationship to vaccine exposure.

Blood and lymphatic system disorders: Autoimmune hemolytic anemia, lymphadenopathy.
Gastrointestinal disorders: Nausea, pancreatitis, vomiting.
General disorders and administration site conditions: Asthenia, death, fatigue, malaise.
Immune system disorders: Autoimmune diseases, hypersensitivity reactions including anaphylactic/anaphylactoid reactions, bronchospasm, and urticaria.
Musculoskeletal and connective tissue disorders: Arthralgia, myalgia.
Nervous system disorders: Dizziness, Guillain-Barré syndrome, headache, motor neuron disease, paralysis, seizures, syncope sometimes resulting in falling with injury, transverse myelitis.
Vascular Disorders: Deep venous thrombosis, pulmonary embolus.

Pediatric Use
Safety and effectiveness have not been established in pediatric patients below 9 years of age nor in pediatric males of any age.

Here is the list of asthma drugs mentioned.

Flovent- growth velocity reduction in children/adolescents, Agitation, aggression, depression, and restlessness. Asthma exacerbation, bronchospasm, chest tightness, cough, dyspnea, immediate bronchospasm, paradoxical bronchospasm, pneumonia, and wheeze. Upper respiratory infection, influenza, Nausea and vomiting, diarrhea, dyspepsia and stomach disorder. weakness, tired feeling, nausea, loss of appetite, weight loss, changes in the shape or location of body fat,

Advair - asthma-related death, Agitation, aggression, anxiety, depression. Behavioral changes, including hyperactivity and irritability, have been reported very rarely and primarily in children. Muscle injuries, fractures, wounds and lacerations, contusions and hematomas, burns, Rhinorrhea/postnasal drip; ear, nose, and throat infections; ear signs and symptoms; nasal signs and symptoms; nasal sinus disorders; rhinitis; sneezing; nasal irritation; blood in nasal mucosa. Sleep disorders, tremors, hypnagogic effects, compressed nerve syndromes, Cushing syndrome, Cushingoid features, growth velocity reduction in children/adolescents, hypercorticism, hyperglycemia, weight gain, osteoporosis

Albuterol - Dizziness; headache; nausea; nervousness; sinus inflammation; sore or dry throat; tremor; trouble sleeping; vomiting. Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); chest pain; ear pain; fast or irregular heartbeat; new or worsened trouble breathing; pounding in the chest; red, swollen, blistered, or peeling skin; severe headache or dizziness; unusual hoarseness; wheezing.

Pulmicort - rash, contact dermatitis, urticaria, angioedema and bronchospasm; symptoms of hypocorticism and hypercorticism; glaucoma, cataracts; psychiatric symptoms including depression, aggressive reactions, irritability, anxiety and psychosis. neck pain, abdominal pain, dry mouth, vomiting, weight gain, insomnia, infection, taste perversion

Symbicort - Long-acting beta2-adrenergic agonists may increase the risk of asthma-related death, psychiatric symptoms, e.g., irritability, anxiety, restlessness, nervousness, agitation, depression; skin bruising. immediate hypersensitivity reactions, such as anaphylactic reaction and bronchospasm; symptoms of hypocorticism and hypercorticism; glaucoma, cataracts, psychiatric symptoms, including aggressive reactions, behavioral disturbances, psychosis.
confusion; insomnia; seizures. dry hair; dry skin; urticaria; rash; pruritus; purpura; photosensitivity; increased sweating; alopecia, erythema multiforme, Conjunctivitis, dysphonia; blurred vision; earache; eye pain; blepharospasm; altered taste, Dry mouth; abdominal pain; anorexia; increased appetite and weight gain; nausea; vomiting; diarrhea; constipation; flatulence; gastritis; dyspepsia; thirst; hiccough; stomatitis. Urinary discoloration; altered micturition; menstrual irregularities; impotence; vaginitis; urinary retention; urinary incontinence; breast enlargement, Wheezing; upper respiratory tract infection; nasal dryness; pharyngitis; epistaxis; nasal congestion; dyspnea; coughing; rhinitis; hemoptysis; sinusitis; sneezing; bronchospasm; bronchitis; laryngitis. Breast pain; arthralgia; myalgia; malaise; chest pain; leg cramps; asthenia; back pain; fever; peripheral edema

Yeah i was taking advair, i hardley used to even have asthma. I might need 1 puff or 2 from inhaler each week. Then i got off advair. Now i need inhaler at least 4-5 times a day. I'm real pissed, i wish i could sue advair. Come to think about it, my sister was on advair a lot longer than me, and around Christmas 2005, she was in hospital in comma, because of advair. They should take it off the market, and pay out billions for the deaths they caused

Anaphylaxis. While under general anesthesia, the patient developed truncal erythema, bronchospasm, and hypotension (BPsys 50-60s) within minutes of lymphazurin administration. The patient recovered after being treated with a 2 L. I.V. fluid bolus, epinephrine, SoluMedrol, Benadryl, and neosynephrine.